Free Trial

Boston Scientific (BSX) Competitors

Boston Scientific logo
$104.42 -0.22 (-0.21%)
Closing price 05/22/2025 03:59 PM Eastern
Extended Trading
$104.98 +0.56 (+0.54%)
As of 05/22/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BSX vs. ABT, ISRG, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.

Boston Scientific vs.

Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking.

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by insiders. Comparatively, 0.5% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Abbott Laboratories has a net margin of 31.95% compared to Boston Scientific's net margin of 11.07%. Abbott Laboratories' return on equity of 20.74% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Abbott Laboratories31.95% 20.74% 11.19%
Boston Scientific 11.07%17.80%9.85%

In the previous week, Boston Scientific had 8 more articles in the media than Abbott Laboratories. MarketBeat recorded 49 mentions for Boston Scientific and 41 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.37 beat Boston Scientific's score of 1.35 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abbott Laboratories
32 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Boston Scientific
36 Very Positive mention(s)
0 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abbott Laboratories$42.34B5.40$13.40B$7.7117.05
Boston Scientific$17.55B8.80$1.85B$1.3776.22

Abbott Laboratories has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.

Boston Scientific received 117 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 70.00% of users gave Abbott Laboratories an outperform vote while only 69.96% of users gave Boston Scientific an outperform vote.

CompanyUnderperformOutperform
Abbott LaboratoriesOutperform Votes
952
70.00%
Underperform Votes
408
30.00%
Boston ScientificOutperform Votes
1069
69.96%
Underperform Votes
459
30.04%

Abbott Laboratories presently has a consensus target price of $142.59, indicating a potential upside of 8.46%. Boston Scientific has a consensus target price of $114.87, indicating a potential upside of 10.01%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Boston Scientific is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.84
Boston Scientific
0 Sell rating(s)
0 Hold rating(s)
22 Buy rating(s)
2 Strong Buy rating(s)
3.08

Summary

Boston Scientific beats Abbott Laboratories on 10 of the 19 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSX vs. The Competition

MetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$154.48B$4.43B$5.34B$19.32B
Dividend YieldN/A43.63%5.21%3.83%
P/E Ratio83.5429.2026.8534.57
Price / Sales8.8065.63387.2334.85
Price / Cash28.8651.0838.2517.51
Price / Book7.006.196.774.69
Net Income$1.85B$67.60M$3.23B$1.02B
7 Day Performance-0.20%-0.58%1.81%-1.73%
1 Month Performance9.96%18.10%10.93%7.51%
1 Year Performance38.54%21.59%17.15%4.13%

Boston Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSX
Boston Scientific
4.5694 of 5 stars
$104.42
-0.2%
$114.87
+10.0%
+38.5%$154.48B$17.55B83.5445,000Positive News
Analyst Forecast
Options Volume
ABT
Abbott Laboratories
4.8724 of 5 stars
$135.38
+0.4%
$142.59
+5.3%
+25.4%$235.54B$42.34B17.70115,000News Coverage
Positive News
ISRG
Intuitive Surgical
4.271 of 5 stars
$560.42
-0.6%
$598.95
+6.9%
+35.4%$200.86B$8.71B87.4312,100Positive News
Analyst Forecast
SYK
Stryker
4.9219 of 5 stars
$393.87
-0.1%
$427.05
+8.4%
+12.8%$150.34B$23.22B50.7651,000Positive News
Analyst Forecast
MDT
Medtronic
4.7752 of 5 stars
$86.90
+0.5%
$96.14
+10.6%
-5.6%$111.45B$33.20B26.4195,000Trending News
Earnings Report
Dividend Increase
Analyst Forecast
Options Volume
BDX
Becton, Dickinson and Company
4.9803 of 5 stars
$176.54
+0.6%
$231.44
+31.1%
-26.6%$50.60B$20.87B29.3377,000Positive News
Analyst Forecast
EW
Edwards Lifesciences
4.3559 of 5 stars
$77.96
-0.1%
$79.60
+2.1%
-17.1%$45.73B$5.52B11.1917,300Positive News
Analyst Forecast
Insider Trade
IDXX
IDEXX Laboratories
3.39 of 5 stars
$520.21
+0.4%
$536.00
+3.0%
-2.5%$41.84B$3.93B48.7510,800News Coverage
Positive News
Analyst Forecast
RMD
ResMed
4.1042 of 5 stars
$252.38
+0.3%
$258.83
+2.6%
+12.5%$37.01B$5.02B29.808,160Positive News
Insider Trade
DXCM
DexCom
4.736 of 5 stars
$86.73
+1.5%
$98.11
+13.1%
-35.0%$34.01B$4.15B60.657,600Positive News
Analyst Forecast
STE
STERIS
4.5553 of 5 stars
$251.81
+0.1%
$264.00
+4.8%
+5.6%$24.74B$5.40B53.4616,000Analyst Upgrade

Related Companies and Tools


This page (NYSE:BSX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners